Inflammatory myofibroblastic tumor: Clinical, morphological, immunohistochemical and molecular features of a pediatric case
- 1 December 2014
- journal article
- case report
- Published by Elsevier BV in Pathology - Research and Practice
- Vol. 210 (12), 1152-1155
- https://doi.org/10.1016/j.prp.2014.03.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumorsCurrent Opinion in Oncology, 2012
- Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostainingUrology Annals, 2012
- Inflammatory myofibroblastic tumorContemporary Clinical Dentistry, 2011
- The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase geneEuropean Journal of Cancer, 2010
- ALK Expression in Rhabdomyosarcomas: Correlation with Histologic Subtype and Fusion StatusPediatric and Developmental Pathology, 2009
- Comparison of the Clinical and Immunohistochemical Features, Including Anaplastic Lymphoma Kinase (ALK) and p53, in Inflammatory Myofibroblastic TumoursJournal of International Medical Research, 2009
- Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladderLaboratory Investigation, 2007
- Inflammatory Myofibroblastic TumorThe American Journal of Surgical Pathology, 2007
- Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosisPediatric Blood & Cancer, 2004
- Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic TumorThe American Journal of Pathology, 2001